$2.1B Roundup Verdict Stands as J&J Talc Trial and Tylenol MDL Heat Up


Your Weekly Tort Talk Briefing

Jon, Marc, and Joe Fantini break down several major developments that are shifting the mass tort landscape as we approach 2026.

Here are the key updates:

🌱 Roundup: Bayer withdrew appeals on several large plaintiff verdicts, including the $2.1 billion Georgia judgment. Similar moves in Philadelphia suggest a broader strategy to resolve high-exposure cases while waiting on the Supreme Court.

🧼 Talc: The first post-bankruptcy ovarian cancer trial against Johnson & Johnson began in California. Early testimony from a former FDA commissioner focused on what the company allegedly knew about talc risks. Additional trials are scheduled for 2026.

💊 Tylenol: The Second Circuit heard arguments on whether the MDL judge went too far in excluding all plaintiff experts. The panel’s questions signal a possible shift that could revive the litigation and reshape the expert standard.

🤖 ChatGPT Suicide Litigation: Several lawsuits now allege individuals interacted with ChatGPT before harming themselves. These cases raise new questions about AI safety and platform responsibility.

Catch the full conversation 👇

video preview

Subscribe to The Jon & Marc Podcast on YouTube, Apple Podcasts, or Spotify for law firm growth strategies and legal marketing news from Jon, Marc, and the industry's top tier legal & marketing professionals.

Follow us on Instagram and TikTok for daily reels and advice.

Get in touch

Your comments and feedback are welcomed, as we strive to bring you the toolkit needed to grow your firm today, and to plan for the future.

113 Cherry St #92768, Seattle, WA 98104-2205
Unsubscribe · Preferences

Jon & Marc

Jon & Marc are marketing technologists, exploring the future of law and legal marketing, interviewing the legal industry’s leaders and boldest thinkers, sharing their insights at the intersection of legal practice and innovation.

Read more from Jon & Marc

The AI Paradox: Automate Less, Win More Most law firms are using AI wrong. This week on the podcast, Jon and Marc sat down with Jerry Zhou, Co-Founder and CEO of Supio, to unpack what separates truly AI-native firms from those still treating it like glorified spell-check. Here's what you'll learn: ⚡️ Why most firms are stuck at "cruise control" with AI 💡 The ChatGPT security risk that's putting your client data at risk 🎯 How AI helped win a $60M verdict by processing 42,000 pages of medical...

Bard PowerPort: The Anatomy of a Defective Device A medical device used on cancer patients should help them, not harm them. But the Bard PowerPort did the opposite in thousands of cases. At MTMP, Jon and Marc sat down with Rebecca Phillips, Director of Mass Torts at The Lanier Law Firm and Co Lead Counsel in the Bard PowerPort MDL, to explain what's actually happening inside this litigation. Inside this episode: 📊 The economics and market structure that make the tort viable ⚖️ The operational...

SEO in 2025: Proof Over Promises In 2025, AI is deciding which law firms clients see first. This week on the podcast, Jon and Marc break down how Google Gemini, ChatGPT, and changing search behaviors are reshaping discovery, reputation, and visibility for law firms everywhere. Tune in and learn: ⚡️ The real reason traffic is down (and why conversions are up) 💡 Why AI doesn’t believe your claims — it checks your evidence 🎥 How video and short-form content are fueling visibility in Gemini 🔍 Why...